UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 887

Sortiert nach

Immunotherapy for Sepsis — A New Approach against an Ancient Foe

The New England journal of medicine, 2010-07, Vol.363 (1), p.87-89

2010

Volltextzugriff (PDF)

Pathogenesis, treatment, and prevention of pneumococcal pneumonia

The Lancet (British edition), 2009-10, Vol.374 (9700), p.1543-1556

2009

Volltextzugriff (PDF)

Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection

mBio, 2020-03, Vol.11 (2)

2020

Volltextzugriff (PDF)

Sepsis definitions: time for change

The Lancet (British edition), 2013-03, Vol.381 (9868), p.774-775

2013

Volltextzugriff (PDF)

A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens

Virulence, 2014-01, Vol.5 (1), p.226-235

2014

Volltextzugriff (PDF)

Molecular biology of inflammation and sepsis : A primer

Critical care medicine, 2009, Vol.37 (1), p.291-304

2009

Volltextzugriff (PDF)

Biomarkers of Infection and Sepsis

Critical care clinics, 2020-01, Vol.36 (1), p.11

2020

Volltextzugriff (PDF)

Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19

The Lancet (British edition), 2020-10, Vol.396 (10259), p.e61-e62

2020

Volltextzugriff (PDF)

Coagulation abnormalities in critically ill patients

Critical care (London, England), 2006-01, Vol.10 (4), p.222-222

2006

Volltextzugriff (PDF)

Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance

Critical care (London, England), 2016-12, Vol.20 (1), p.397-397, Article 397

Opal, Steven M

2016

Volltextzugriff (PDF)

Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis

JAMA : the journal of the American Medical Association, 2019-05, Vol.321 (20), p.2003

2019

Volltextzugriff (PDF)

Host–pathogen interactions in sepsis

The Lancet infectious diseases, 2008, Vol.8 (1), p.32-43

2008

Volltextzugriff (PDF)

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

JAMA : the journal of the American Medical Association, 2016-02, Vol.315 (8), p.801

2016

Volltextzugriff (PDF)

Activating Immunity to Fight a Foe — A New Path

The New England journal of medicine, 2020-03, Vol.382 (13), p.1270-1272

2020

Volltextzugriff (PDF)

Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial

Critical care medicine, 2016-02, Vol.44 (2), p.275-281

2016

Volltextzugriff (PDF)

Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock

International journal of molecular sciences, 2021-02, Vol.22 (4), p.2228

2021

Volltextzugriff (PDF)

Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia

Critical care (London, England), 2010-01, Vol.14 (1), p.203-203

2010

Volltextzugriff (PDF)

Severe Pneumonia Caused by Legionella pneumophila: Differential Diagnosis and Therapeutic Considerations

Infectious disease clinics of North America, 2017-03, Vol.31 (1), p.111

2017

Volltextzugriff (PDF)

Proprotein Convertases in Health and Disease

The New England journal of medicine, 2011-12, Vol.365 (26), p.2507-2518

2011

Volltextzugriff (PDF)

Sepsis and septic shock

Nature reviews. Disease primers, 2016-06, Vol.2 (1), p.16045-16045, Article 16045

2016

Volltextzugriff (PDF)

Source Control in Sepsis Urgent or Not So Fast?

Critical care medicine, 2017-01, Vol.45 (1), p.130-132

Opal, Steven M

2017

Volltextzugriff (PDF)

The Next Generation of Sepsis Clinical Trial Designs: What Is Next After the Demise of Recombinant Human Activated Protein C?

Critical care medicine, 2014-07, Vol.42 (7), p.1714-1721

2014

Volltextzugriff (PDF)

Should all septic patients be given systemic anticoagulation? No

Intensive care medicine, 2017-03, Vol.43 (3), p.455-457

2017

Volltextzugriff (PDF)

The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis

International journal of medical microbiology, 2007-09, Vol.297 (5), p.365-377

Opal, Steven M

2007

Volltextzugriff (PDF)

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012

Critical care medicine, 2013-02, Vol.41 (2), p.580-637

2013

Volltextzugriff (PDF)

1 – 25 von 887

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(350)
Mit Volltextzugriff
(336)

Publikationsform

Sprache

Englisch
(886)
Japanisch
(42)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunotherapy for Sepsis — A New Approach against an Ancient Foe

Pathogenesis, treatment, and prevention of pneumococcal pneumonia

Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection

Sepsis definitions: time for change

A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens

Molecular biology of inflammation and sepsis : A primer

Biomarkers of Infection and Sepsis

Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19

Coagulation abnormalities in critically ill patients

Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance

Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis

Host–pathogen interactions in sepsis

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Activating Immunity to Fight a Foe — A New Path

Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial

Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock

Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia

Severe Pneumonia Caused by Legionella pneumophila: Differential Diagnosis and Therapeutic Considerations

Proprotein Convertases in Health and Disease

Sepsis and septic shock

Source Control in Sepsis Urgent or Not So Fast?

The Next Generation of Sepsis Clinical Trial Designs: What Is Next After the Demise of Recombinant Human Activated Protein C?

Should all septic patients be given systemic anticoagulation? No

The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012

Suchergebnisse filtern